Geode Capital Management, LLC Nurix Therapeutics, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Nurix Therapeutics, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,100,335 shares of NRIX stock, worth $24.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,100,335

Previous 1,080,523 1.83%

Holding current value

$24.1 Million

Previous $11.2 Million 45.06%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.77 - $15.66 $153,939 - $310,255	19,812 Added 1.83%	1,100,335 $16.2 Million
Q4 2023 Feb 13, 2024	BUY	$4.25 - $10.71 $149,761 - $377,398	35,238 Added 3.37%	1,080,523 $11.2 Million
Q3 2023 Nov 13, 2023	BUY	$7.86 - $10.08 $528,459 - $677,718	67,234 Added 6.87%	1,045,285 $8.22 Million
Q2 2023 Aug 11, 2023	BUY	$8.7 - $13.28 $412,031 - $628,940	47,360 Added 5.09%	978,051 $9.77 Million
Q1 2023 May 15, 2023	BUY	$8.56 - $13.26 $312,226 - $483,658	36,475 Added 4.08%	930,691 $8.26 Million

Q4 2022 Feb 13, 2023	BUY	$9.86 - $14.59 $766,654 - $1.13 Million	77,754 Added 9.52%	894,216 $9.82 Million
Q3 2022 Nov 14, 2022	BUY	$12.33 - $19.81 $532,261 - $855,158	43,168 Added 5.58%	816,462 $10.6 Million
Q2 2022 Aug 12, 2022	BUY	$7.88 - $14.82 $951,904 - $1.79 Million	120,800 Added 18.51%	773,294 $9.8 Million
Q1 2022 May 13, 2022	BUY	$12.94 - $29.65 $400,454 - $917,578	30,947 Added 4.98%	652,494 $9.14 Million
Q4 2021 Feb 11, 2022	SELL	$26.43 - $34.5 $241,860 - $315,709	-9,151 Reduced 1.45%	621,547 $18 Million
Q3 2021 Nov 12, 2021	BUY	$22.71 - $36.69 $5.36 Million - $8.66 Million	235,941 Added 59.77%	630,698 $18.9 Million
Q2 2021 Aug 13, 2021	BUY	$24.21 - $35.89 $1.72 Million - $2.56 Million	71,237 Added 22.02%	394,757 $10.5 Million
Q1 2021 May 12, 2021	BUY	$26.98 - $50.17 $3.35 Million - $6.24 Million	124,287 Added 62.38%	323,520 $10.1 Million
Q4 2020 Feb 12, 2021	BUY	$22.85 - $48.44 $350,313 - $742,633	15,331 Added 8.34%	199,233 $6.55 Million
Q3 2020 Nov 13, 2020	BUY	$16.05 - $34.91 $2.95 Million - $6.42 Million	183,902 New	183,902 $6.42 Million

Others Institutions Holding NRIX

# of Institutions

146

Shares Held

50M

Call Options Held

30.3K

Put Options Held

22.7K

View Full List

About Nurix Therapeutics, Inc.

Ticker NRIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,147,800
Market Cap $1.03B
Description
Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...

More about NRIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Nurix Therapeutics, Inc. Transaction History